| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| B330520-25mg |
25mg |
期货  |
|
| 英文别名 | Bosutinib,SKI-606 | BSPBio_001023 | NCGC00241107-03 | NSC799367 | NSC-799367 | 4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)propoxy]quinoline-3-carbonitrile | 5018V4AEZ0 | DB06616 | SK 606 | 2-[4-(2,3-dihydro-1,4-benzodio |
|---|---|
| 英文名称 | Bosutinib Isomer 1, Free Base |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
伯舒替尼异构体1，游离碱，是伯舒替尼的不正确异构体，不具有与真正的伯舒替尼相同的激酶抑制能力。 Bosutinib Isomer 1, Free Base, is an incorrect isomer of bosutinib and does not possess the same kinase inhibitory capacity as true bosutinib. |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| Isomeric SMILES | CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC |
| PubChem CID | 5328940 |
| 分子量 | 530.45 |
| 溶解性 | Soluble in DMSO (33 mg/ml), ethanol (10 mg/ml, with warming), and water (very poorly).maximum solubility in plain water is etimated to be about 10-50 μM; buffers, serum, or other additives may increase or decrease the aqueous solubility |
|---|---|
| 熔点 | 210-221° C |
| 分子量 | 530.400 g/mol |
| XLogP3 | 5.400 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 9 |
| 精确质量Exact Mass | 529.165 Da |
| 单同位素质量Monoisotopic Mass | 529.165 Da |
| 拓扑极表面积Topological Polar Surface Area | 82.900 Ų |
| 重原子数Heavy Atom Count | 36 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 734.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 信号词 | 警告 |
|---|---|
| 危险声明 |
H320: 引起眼睛刺激 H335: 可能引起呼吸道刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P264: 处理后要彻底洗手。 |
首页
400-620-6333
